Damia G - Search Results

1

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.

Chiappa M, Petrella S, Damia G, Broggini M, Guffanti F, Ricci F. Chiappa M, et al. Among authors: damia g. Front Oncol. 2022 Jun 2;12:903016. doi: 10.3389/fonc.2022.903016. eCollection 2022. Front Oncol. 2022. PMID: 35719948 Free PMC article. Review.

2

DNA Damage Induces p53-dependent Down-regulation of hCHK1.

Damia G, Sanchez Y, Erba E, Broggini M. Damia G, et al. J Biol Chem. 2001 Apr 6;276(14):10641-5. doi: 10.1074/jbc.M007178200. Epub 2001 Jan 4. J Biol Chem. 2001. PMID: 11152453 Free article.

3

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.

Marchini S, Damia G, Broggini M, Pennella G, Ripamonti M, Marsiglio A, Geroni C. Marchini S, et al. Among authors: damia g. Cancer Res. 2001 Mar 1;61(5):1991-5. Cancer Res. 2001. PMID: 11280757

4

Cisplatinum and taxol induce different patterns of p53 phosphorylation.

Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, D'incalci M, Broggini M. Damia G, et al. Neoplasia. 2001 Jan-Feb;3(1):10-6. doi: 10.1038/sj.neo.7900122. Neoplasia. 2001. PMID: 11326311 Free PMC article.

5

Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.

Carrassa L, Broggini M, Vikhanskaya F, Damia G. Carrassa L, et al. Among authors: damia g. Cell Cycle. 2003 Nov-Dec;2(6):604-9. Cell Cycle. 2003. PMID: 14504477

6

Cell cycle checkpoint proteins and cellular response to treatment by anticancer agents.

Damia G, Broggini M. Damia G, et al. Cell Cycle. 2004 Jan;3(1):46-50. Cell Cycle. 2004. PMID: 14657665 Review.

7

Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.

Carrassa L, Broggini M, Erba E, Damia G. Carrassa L, et al. Among authors: damia g. Cell Cycle. 2004 Sep;3(9):1177-81. Epub 2004 Sep 13. Cell Cycle. 2004. PMID: 15326376

8

Improving the selectivity of cancer treatments by interfering with cell response pathways.

Damia G, Broggini M. Damia G, et al. Eur J Cancer. 2004 Nov;40(17):2550-9. doi: 10.1016/j.ejca.2004.07.020. Eur J Cancer. 2004. PMID: 15541958 Review.

9

Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.

Ganzinelli M, Carrassa L, Crippa F, Tavecchio M, Broggini M, Damia G. Ganzinelli M, et al. Among authors: damia g. Clin Cancer Res. 2008 Aug 15;14(16):5131-41. doi: 10.1158/1078-0432.CCR-08-0304. Clin Cancer Res. 2008. PMID: 18698031

10

Role of Chk1 in the differentiation program of hematopoietic stem cells.

Carrassa L, Montelatici E, Lazzari L, Zangrossi S, Simone M, Broggini M, Damia G. Carrassa L, et al. Among authors: damia g. Cell Mol Life Sci. 2010 May;67(10):1713-22. doi: 10.1007/s00018-010-0274-1. Epub 2010 Feb 10. Cell Mol Life Sci. 2010. PMID: 20146081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page